Melior Discovery
From Wikipedia, the free encyclopedia
 | |
| Company type | Private company |
|---|---|
| Industry | Biotechnology |
| Founded | 2005 |
| Founder | Andrew Reaume Michael Saporito |
| Headquarters | Exton, Pennsylvania |
| Products | Pharmaceuticals, contract research |
| Website | www |
Melior Discovery, Inc. is a private biopharmaceutical company based in Exton, Pennsylvania, USA.
The company specializes in drug repositioning and has established a proprietary phenotypic screening platform that it uses for this purpose. Melior also offers certain contract research organization (CRO) services comprising animal models representing different disease conditions.[citation needed]
The Company has issued press releases disclosing partnerships with Pfizer, Merck & Co., Johnson & Johnson, and AstraZeneca, all citing the use of the company's drug repositioning technology. Melior Discovery has also used its technology to discover its own drug candidates.[citation needed]
